188 related articles for article (PubMed ID: 31646085)
1. Evidence for interaction of the NLRP3 inflammasome and Bruton's tyrosine kinase in tumor-associated macrophages: implications for myeloid cell production of interleukin-1beta.
Benner B; Scarberry L; Stiff A; Duggan MC; Good L; Lapurga G; Butchar JP; Tridandapani S; Carson WE
Oncoimmunology; 2019; 8(11):1659704. PubMed ID: 31646085
[TBL] [Abstract][Full Text] [Related]
2. Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.
Liu X; Pichulik T; Wolz OO; Dang TM; Stutz A; Dillen C; Delmiro Garcia M; Kraus H; Dickhöfer S; Daiber E; Münzenmayer L; Wahl S; Rieber N; Kümmerle-Deschner J; Yazdi A; Franz-Wachtel M; Macek B; Radsak M; Vogel S; Schulte B; Walz JS; Hartl D; Latz E; Stilgenbauer S; Grimbacher B; Miller L; Brunner C; Wolz C; Weber ANR
J Allergy Clin Immunol; 2017 Oct; 140(4):1054-1067.e10. PubMed ID: 28216434
[TBL] [Abstract][Full Text] [Related]
3. Bruton's tyrosine kinase drives neuroinflammation and anxiogenic behavior in mouse models of stress.
Ghosh S; Mohammed Z; Singh I
J Neuroinflammation; 2021 Dec; 18(1):289. PubMed ID: 34895246
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Bruton's TK regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation.
Purvis GSD; Collino M; Aranda-Tavio H; Chiazza F; O'Riordan CE; Zeboudj L; Mohammad S; Collotta D; Verta R; Guisot NES; Bunyard P; Yaqoob MM; Greaves DR; Thiemermann C
Br J Pharmacol; 2020 Oct; 177(19):4416-4432. PubMed ID: 32608058
[TBL] [Abstract][Full Text] [Related]
5. Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury.
Ito M; Shichita T; Okada M; Komine R; Noguchi Y; Yoshimura A; Morita R
Nat Commun; 2015 Jun; 6():7360. PubMed ID: 26059659
[TBL] [Abstract][Full Text] [Related]
6. Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironment.
Good L; Benner B; Carson WE
Cancer Immunol Immunother; 2021 Sep; 70(9):2439-2451. PubMed ID: 33818636
[TBL] [Abstract][Full Text] [Related]
7. Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice.
O'Riordan CE; Purvis GSD; Collotta D; Chiazza F; Wissuwa B; Al Zoubi S; Stiehler L; Martin L; Coldewey SM; Collino M; Thiemermann C
Front Immunol; 2019; 10():2129. PubMed ID: 31552054
[TBL] [Abstract][Full Text] [Related]
8. The NLRP3 inflammasome and bruton's tyrosine kinase in platelets co-regulate platelet activation, aggregation, and in vitro thrombus formation.
Murthy P; Durco F; Miller-Ocuin JL; Takedai T; Shankar S; Liang X; Liu X; Cui X; Sachdev U; Rath D; Lotze MT; Zeh HJ; Gawaz M; Weber AN; Vogel S
Biochem Biophys Res Commun; 2017 Jan; 483(1):230-236. PubMed ID: 28034752
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.
Stiff A; Trikha P; Wesolowski R; Kendra K; Hsu V; Uppati S; McMichael E; Duggan M; Campbell A; Keller K; Landi I; Zhong Y; Dubovsky J; Howard JH; Yu L; Harrington B; Old M; Reiff S; Mace T; Tridandapani S; Muthusamy N; Caligiuri MA; Byrd JC; Carson WE
Cancer Res; 2016 Apr; 76(8):2125-36. PubMed ID: 26880800
[TBL] [Abstract][Full Text] [Related]
10. BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity.
Bittner ZA; Liu X; Mateo Tortola M; Tapia-Abellán A; Shankar S; Andreeva L; Mangan M; Spalinger M; Kalbacher H; Düwell P; Lovotti M; Bosch K; Dickhöfer S; Marcu A; Stevanović S; Herster F; Cardona Gloria Y; Chang TH; Bork F; Greve CL; Löffler MW; Wolz OO; Schilling NA; Kümmerle-Deschner JB; Wagner S; Delor A; Grimbacher B; Hantschel O; Scharl M; Wu H; Latz E; Weber ANR
J Exp Med; 2021 Nov; 218(11):. PubMed ID: 34554188
[TBL] [Abstract][Full Text] [Related]
11. Targeting the NLRP3 Inflammasome via BTK.
Weber ANR
Front Cell Dev Biol; 2021; 9():630479. PubMed ID: 33718366
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.
Park HY; Chae MK; Ko J; Kikkawa DO; Jang SY; Yoon JS
PLoS One; 2022; 17(12):e0279060. PubMed ID: 36521376
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) Function.
Ren L; Campbell A; Fang H; Gautam S; Elavazhagan S; Fatehchand K; Mehta P; Stiff A; Reader BF; Mo X; Byrd JC; Carson WE; Butchar JP; Tridandapani S
J Biol Chem; 2016 Feb; 291(6):3043-52. PubMed ID: 26627823
[TBL] [Abstract][Full Text] [Related]
14. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
15. Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity.
Weber ANR; Bittner Z; Liu X; Dang TM; Radsak MP; Brunner C
Front Immunol; 2017; 8():1454. PubMed ID: 29167667
[TBL] [Abstract][Full Text] [Related]
16. Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitis.
Mao L; Kitani A; Hiejima E; Montgomery-Recht K; Zhou W; Fuss I; Wiestner A; Strober W
J Clin Invest; 2020 Apr; 130(4):1793-1807. PubMed ID: 31895698
[TBL] [Abstract][Full Text] [Related]
17. The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages.
Ping L; Ding N; Shi Y; Feng L; Li J; Liu Y; Lin Y; Shi C; Wang X; Pan Z; Song Y; Zhu J
Oncotarget; 2017 Jun; 8(24):39218-39229. PubMed ID: 28424405
[TBL] [Abstract][Full Text] [Related]
18. Role of Bruton's tyrosine kinase in B cells and malignancies.
Pal Singh S; Dammeijer F; Hendriks RW
Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
[TBL] [Abstract][Full Text] [Related]
19. Efferocytosis drives myeloid NLRP3 dependent inflammasome signaling secretion of IL-1β to promote tumor growth.
Lang C; Roy S; Wang Y; Graves D; Xu Y; Serezani CH; Korrer M; Kim YJ
Front Immunol; 2022; 13():993771. PubMed ID: 36439171
[TBL] [Abstract][Full Text] [Related]
20. CD38-mediated Inhibition of Bruton's Tyrosine Kinase in Macrophages Prevents Endotoxemic Lung Injury.
Farahany J; Tsukasaki Y; Mukhopadhyay A; Mittal M; Nepal S; Tiruppathi C; Malik AB
Am J Respir Cell Mol Biol; 2022 Feb; 66(2):183-195. PubMed ID: 34706199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
